These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 8875416)
1. 5-Fluorouracil metabolite patterns in viable and necrotic tumor areas of murine colon carcinoma determined by 19F NMR spectroscopy. Kamm YJ; Heerschap A; Rosenbusch G; Rietjens IM; Vervoort J; Wagener DJ Magn Reson Med; 1996 Sep; 36(3):445-50. PubMed ID: 8875416 [TBL] [Abstract][Full Text] [Related]
2. Effect of modulators on 5-fluorouracil metabolite patterns in murine colon carcinoma determined by in vitro 19F nuclear magnetic resonance spectroscopy. Kamm VJ; Rietjens IM; Vervoort J; Heerschap A; Rosenbusch G; Hofs HP; Wagener DJ Cancer Res; 1994 Aug; 54(16):4321-6. PubMed ID: 8044779 [TBL] [Abstract][Full Text] [Related]
3. Metabolites of 5-fluorouracil in plasma and urine, as monitored by 19F nuclear magnetic resonance spectroscopy, for patients receiving chemotherapy with or without methotrexate pretreatment. Hull WE; Port RE; Herrmann R; Britsch B; Kunz W Cancer Res; 1988 Mar; 48(6):1680-8. PubMed ID: 3125967 [TBL] [Abstract][Full Text] [Related]
4. 19F NMR monitoring of in vivo tumor metabolism after biochemical modulation of 5-fluorouracil by the uridine phosphorylase inhibitor 5-benzylacyclouridine. Holland SK; Bergman AM; Zhao Y; Adams ER; Pizzorno G Magn Reson Med; 1997 Dec; 38(6):907-16. PubMed ID: 9402191 [TBL] [Abstract][Full Text] [Related]
5. Effect of carbogen breathing on the pharmacodynamics of 5-fluorouracil in a murine colon carcinoma. Kamm YJ; Heerschap A; Wagener DJ Eur J Cancer; 2000 Jun; 36(9):1180-6. PubMed ID: 10854952 [TBL] [Abstract][Full Text] [Related]
6. Thymidine-modulated 5-fluorouracil metabolism in liver and RIF-1 tumors studied by 19F magnetic resonance spectroscopy. Sijens PE; Ng TC Magn Reson Imaging; 1992; 10(3):385-92. PubMed ID: 1406088 [TBL] [Abstract][Full Text] [Related]
7. In vivo effect of 5-ethynyluracil on 5-fluorouracil metabolism determined by 19F nuclear magnetic resonance spectroscopy. Adams ER; Leffert JJ; Craig DJ; Spector T; Pizzorno G Cancer Res; 1999 Jan; 59(1):122-7. PubMed ID: 9892196 [TBL] [Abstract][Full Text] [Related]
8. Fluoropyrimidine chemotherapy in a rat model: comparison of fluorouracil metabolite profiles determined by high-field 19F-NMR spectroscopy of tissues ex vivo with therapy response and toxicity for locoregional vs systemic infusion protocols. Lutz NW; Naser-Hijazi B; Koroma S; Berger MR; Hull WE NMR Biomed; 2004 May; 17(3):101-31. PubMed ID: 15137037 [TBL] [Abstract][Full Text] [Related]
9. 5-Fluorouracil metabolism and cytotoxicity after pre-treatment with methotrexate or thymidine in human hypopharynx and colon carcinoma xenografts: a 19F-nuclear magnetic resonance spectroscopy study in vivo. Tausch-Treml R; Baumgart F; Ziessow D; Köpf-Maier P Cancer Chemother Pharmacol; 1996; 37(3):259-65. PubMed ID: 8529287 [TBL] [Abstract][Full Text] [Related]
10. 19F magnetic resonance spectroscopy studies of the metabolism of 5-fluorouracil in murine RIF-1 tumors and liver. Sijens PE; Huang YM; Baldwin NJ; Ng TC Cancer Res; 1991 Mar; 51(5):1384-90. PubMed ID: 1997177 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of 5-fluorouracil and its catabolites determined by 19F nuclear magnetic resonance spectroscopy for a patient on chronic hemodialysis. Rengelshausen J; Hull WE; Schwenger V; Göggelmann C; Walter-Sack I; Bommer J Am J Kidney Dis; 2002 Feb; 39(2):E10. PubMed ID: 11840401 [TBL] [Abstract][Full Text] [Related]
12. Drug monitoring of 5-fluorouracil: in vivo 19F NMR study during 5-FU chemotherapy in patients with metastases of colorectal adenocarcinoma. Schlemmer HP; Bachert P; Semmler W; Hohenberger P; Schlag P; Lorenz WJ; van Kaick G Magn Reson Imaging; 1994; 12(3):497-511. PubMed ID: 8007780 [TBL] [Abstract][Full Text] [Related]
13. In vivo monitoring of changes in 5-fluorouracil metabolism induced by methotrexate measured by 19F NMR spectroscopy. Koutcher JA; Sawyer RC; Kornblith AB; Stolfi RL; Martin DS; Devitt ML; Cowburn D; Young CW Magn Reson Med; 1991 May; 19(1):113-23. PubMed ID: 2046526 [TBL] [Abstract][Full Text] [Related]
14. Proton-decoupled 19F spectroscopy of 5-FU catabolites in human liver. Murphy-Boesch J; Li CW; He L; Padavic-Shaller KA; Negendank W; Brown TR Magn Reson Med; 1997 Mar; 37(3):321-6. PubMed ID: 9055218 [TBL] [Abstract][Full Text] [Related]
15. Real-time follow-up of 5-fluorouracil metabolism in the liver of tumor patients by means of F-19 MR spectroscopy. Semmler W; Bachert-Baumann P; Gückel F; Ermark F; Schlag P; Lorenz WJ; van Kaick G Radiology; 1990 Jan; 174(1):141-5. PubMed ID: 2104675 [TBL] [Abstract][Full Text] [Related]
16. [In-vivo 19F-MRS study of 5-fluorouracil (5-FU) metabolism on tumors]. Harada M; Nishitani H; Shirahama T; Koga K; Miura I Gan To Kagaku Ryoho; 1991 Jan; 18(1):75-80. PubMed ID: 1899014 [TBL] [Abstract][Full Text] [Related]
17. Assignment and pH dependence of the 19F-NMR resonances from the fluorouracil anabolites involved in fluoropyrimidine chemotherapy. Lutz NW; Hull WE NMR Biomed; 1999 Jun; 12(4):237-48. PubMed ID: 10421915 [TBL] [Abstract][Full Text] [Related]
19. Effect of folinic acid on fluorouracil activity and expression of thymidylate synthase. van der Wilt CL; Pinedo HM; Smid K; Cloos J; Noordhuis P; Peters GJ Semin Oncol; 1992 Apr; 19(2 Suppl 3):16-25. PubMed ID: 1532671 [TBL] [Abstract][Full Text] [Related]
20. Quantitation of 5-fluorouracil catabolism in human liver in vivo by three-dimensional localized 19F magnetic resonance spectroscopy. Li CW; Negendank WG; Padavic-Shaller KA; O'Dwyer PJ; Murphy-Boesch J; Brown TR Clin Cancer Res; 1996 Feb; 2(2):339-45. PubMed ID: 9816177 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]